Abstract

To investigate age-related persistence with bisphosphonates (BIS) in women with breast cancer (BC) and bone metastases. We included a dataset of 1541 patients diagnosed with BC and bone metastases and initially treated with BIS between 1994 and 2013. The primary outcome measure was [...]